In the News

/In the News

MVRF-Funded Researcher, Dr. Sally Temple, Makes Guest Appearance on the Dr. Oz Show

Video of Dr. Temple on the Dr. Oz Show On Tuesday, February 14, 2017, NSCI’s Scientific Director and MVRF-funded researcher, Dr. Sally Temple was a guest on the Dr.Oz Show: Dr. Temple was asked to participate on the show as a stem cell expert and the current President of the International Society for Stem Cell [...]

May 2nd, 2017|

Penn Team Characterizes the Underlying Cause of a Form of Macular Degeneration

Named for Friedrich Best, who characterized the disease in 1905, Best disease, also known as vitelliform macular dystrophy, affects children and young adults and can cause severe declines in central vision as patients age. The disease is one in a group of conditions known as bestrophinopathies, all linked to mutations in the BEST1 gene. This [...]

April 25th, 2017|

One stem cell treatment stabilizes macular degeneration, another blinds 3 patients

(CNN) As we grow older, a common disease called macular degeneration can threaten our eyesight. An experimental stem cell treatment proved effective at halting this disease with no serious side effects up to a year later, a study published Wednesday in the New England Journal of Medicine found. It is the first treatment using personalized, genetically [...]

March 17th, 2017|

The Macula Vision Research Foundation (MVRF) & VisionCare, Inc. Announce Partnership to Increase Awareness of Treatments for Age-Related Macular Degeneration

The Macula Vision Research Foundation (MVRF) and VisionCare, Inc. have formed a unique partnership of industry and philanthropy to benefit more than 15 million people in the United States with age-related macular degeneration (AMD). The goal of this partnership is to increase awareness of potential treatments for AMD including the CentraSight treatment program, which includes [...]

March 9th, 2017|

Researchers Develop Best-Yet Cell Culture System for Age-Related Macular Degeneration

An international team from the University of Alabama at Birmingham and University College London and Queens University Belfast in the United Kingdom developed a cell culture model that could help to develop earlier treatment strategies for age-related macular degeneration, the third most prevalent cause of vision loss worldwide. In AMD, which is twice as prevalent [...]

February 22nd, 2017|

Clinical Trial Update: Squalamine Eye Drops for Wet Macular Degeneration

Many readers have been following closely the development of Squalamine Eye Drops for wet age-related macular degeneration, hoping that a self-administered at-home eye drop could reduce, or even eliminate, the need for monthly or as-needed eye injections. Unfortunately, a clinical trial designed to test this concept has produced disappointing results: Squalamine Eye Drops failed to [...]

January 24th, 2017|

FDA APPROVES GENENTECH’S LUCENTIS® (RANIBIZUMAB INJECTION) PREFILLED SYRINGE

Lucentis prefilled syringe offers a ready-to-use option to deliver treatment with fewer steps First anti-VEGF prefilled syringe FDA-approved to treat people with wet age-related macular degeneration and people with macular edema after retinal vein occlusion SOUTH SAN FRANCISCO, Calif. – October 14, 2016 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: [...]

October 19th, 2016|

National Geographic’s Cover Story September 2016 Issue features important info on AMD

Curing blindness is a big deal! Check out National Geographic's Cover Story September 2016 Issue featuring important information on AMD that the world needs to know more about. We are even more optimistic! Link to article: http://www.nationalgeographic.com/magazine/2016/09/blindness-treatment-medical-science-cures/

September 22nd, 2016|

MVRF is Co-Sponsoring Emerging Vision Scientists Day

MVRF is Proud to Co-Sponsor the Second Annual Emerging Vision Scientists Day on Capitol Hill On September 14, 2016, we will be co-hosting a special Congressional Briefing entitled, Advances in the Diagnosis and Treatment of Age-Related Macular Degeneration (AMD) and Retinal Diseases presented by Amir H. Kashani, MD, PhD (USC Gayle and Edward Roski Eye Institute/Keck School [...]

September 13th, 2016|

Could Broccoli Be The Key To Treating AMD?

A fascinating article about one of MVRF's favorite super foods possibly being a treatment method for AMD. Studies at the Buck Institute for Research on Aging have been conducted that link a higher potency of broccoli compounds in the treatment of AMD. Read more about this interesting study here!   

July 26th, 2016|